Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,033	13,820	12,946	11,482	8,080	8,955
Market Cap Growth	6.76%	6.76%	12.74%	42.11%	-9.78%	-9.54%
Enterprise Value	11,453	12,878	12,124	10,966	7,766	8,528
Last Close Price	120.69	136.50	131.76	119.44	85.17	95.85
PE Ratio	36.68	40.49	51.84	74.32	90.18	21.99
Forward PE	18.68	18.15	21.34	22.53	24.55	22.30
PS Ratio	5.14	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.63	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	5.43	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	21.60	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	20.21	23.21	33.20	33.83	31.50	39.19
PEG Ratio	0.40	0.31	0.65	0.66	0.37	0.37
EV/Sales Ratio	4.86	5.47	6.42	7.37	6.85	8.15
EV/EBITDA Ratio	18.77	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	19.64	22.09	30.71	44.04	37.37	26.04
EV/FCF Ratio	20.55	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.19	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.89	0.89	1.18	0.81	1.89	1.89
Asset Turnover	0.68	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	15.99	15.99	16.48	14.85	11.71	12.59
Quick Ratio	3.06	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.40	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.16%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	10.46%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	12.68%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	18.16%	18.16%	15.20%	13.60%	11.38%	21.15%
Earnings Yield	2.84%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.63%	4.03%	2.79%	2.81%	2.88%	2.43%
Buyback Yield / Dilution	-2.67%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%
Total Shareholder Return	-2.67%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Capital IQ. Standard template. Financial Sources.